Human hepatitis B virus-derived virus-like particle as a drug and DNA delivery carrier.
暂无分享,去创建一个
[1] M. Fujimuro,et al. Kaposi's sarcoma-associated herpesvirus ORF17 plays a key role in capsid maturation. , 2021, Virology.
[2] Wilfred Chen,et al. Modular Hepatitis B Virus-Like Particle Platform for Biosensing and Drug Delivery. , 2020, ACS nano.
[3] E. Blanchard,et al. Hepatitis B Virus Entry into Cells , 2020, Cells.
[4] M. Fujimuro,et al. MG132 exerts anti-viral activity against HSV-1 by overcoming virus-mediated suppression of the ERK signaling pathway , 2020, Scientific Reports.
[5] Jianxiang Zhang,et al. Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy. , 2019, Biomaterials.
[6] M. Seno,et al. Synthesis and assembly of Hepatitis B virus envelope protein-derived particles in Escherichia coli. , 2017, Biochemical and biophysical research communications.
[7] T. Liang,et al. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. , 2017, Journal of hepatology.
[8] M. Fälth,et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. , 2014, Gastroenterology.
[9] Hussein H. Aly,et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. , 2014, Biochemical and biophysical research communications.
[10] X. Wu,et al. Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.
[11] Wenhui Li,et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. , 2012, eLife.
[12] J. Wands,et al. Impairment of Hepatitis B Virus Virion Secretion by Single-Amino-Acid Substitutions in the Small Envelope Protein and Rescue by a Novel Glycosylation Site , 2010, Journal of Virology.
[13] S. Urban,et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. , 2005, Gastroenterology.
[14] S. Urban,et al. Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein , 2004, Journal of Virology.
[15] W. Gerlich,et al. Pre-S1 Antigen-Dependent Infection of Tupaia Hepatocyte Cultures with Human Hepatitis B Virus , 2003, Journal of Virology.
[16] A. Kondo,et al. Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.
[17] R. Perez-soler,et al. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. , 1996, Molecular pharmacology.
[18] K. Matsubara,et al. Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles , 1991, Journal of virology.
[19] D. Ganem,et al. The role of envelope proteins in hepatitis B virus assembly. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[20] D. Ganem,et al. Assembly of hepadnaviral virions and subviral particles. , 1991, Current topics in microbiology and immunology.
[21] H. Varmus,et al. The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.
[22] H. Varmus,et al. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. , 1986, Science.
[23] R. Palmiter,et al. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice , 1986, Journal of virology.
[24] W. Gerlich,et al. Large surface proteins of hepatitis B virus containing the pre-s sequence , 1984, Journal of virology.
[25] M. Hilleman,et al. Human hepatitis B vaccine from recombinant yeast , 1984, Nature.